Page 1 of Clinical Trials for Cephalon [SPONSOR-COLLABORATORS], 166 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Study of CEP-701 in Treatment of Prostate Cancer
Last Updated: September 14, 2005
Condition(s): Prostate Cancer
2
Completed
Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain
Last Updated: November 9, 2007
Condition(s): Low Back Pain; Migraine; Diabetic Neuropathies; Osteoarthritis
3
Terminated
Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia
Last Updated: May 5, 2011
Condition(s): Acute Myeloid Leukemia
4
Completed
Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia
Last Updated: May 31, 2010
Condition(s): Schizophrenia
5
Completed
Study to Evaluate the Efficacy and Tolerability of Armodafinil Treatment in Adult Patients With Excessive Sleepiness Associated With Shift Work Disorder
Last Updated: March 15, 2011
Condition(s): Hypersomnia
6
Completed
Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome
Last Updated: October 2, 2006
Condition(s): Sleep Apnea, Obstructive
7
Completed
Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain
Last Updated: November 9, 2007
Condition(s): Pain
8
Terminated
Safety and Efficacy of SDX-101 (R-Etodolac) in Patients With Relapsed or Refractory Multiple Myeloma (MM)
Last Updated: April 19, 2006
Condition(s): Multiple Myeloma
9
Completed
Study to Evaluate the Efficacy of Modafinil Treatment in Patients With Attention Deficit Hyperactivity Disorder (ADHD) Who Are Responders to Modafinil Treatment
Last Updated: June 18, 2008
Condition(s): Attention Deficit Hyperactivity Disorder
10
Completed
Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder
Last Updated: March 26, 2010
Condition(s): Narcolepsy; Sleep Apnea, Obstructive; Sleep Apnea Syndromes; Shift-Work Sleep Disorder
11
Completed
A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder
Last Updated: May 26, 2006
Condition(s): Anxiety Disorder
12
Completed
Study to Evaluate Armodafinil Treatment in Improving Prefrontal Cortical Activation and Working Memory Performance
Last Updated: February 26, 2011
Condition(s): Hypersomnia
13
Completed
Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe Psoriasis
Last Updated: February 21, 2008
Condition(s): Psoriasis
14
Completed
Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome(OSAHS)
Last Updated: July 6, 2010
Condition(s): Obstructive Sleep Apnea; Hypopnea
15
Terminated
Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma
Last Updated: September 5, 2006
Condition(s): Myeloma
16
Terminated
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
Last Updated: February 9, 2012
Condition(s): Fatigue; Chemotherapy Side Effects
17
Completed
Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients
Last Updated: December 30, 2011
Condition(s): Cancers, Pain
18
Completed
Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain
Last Updated: November 9, 2007
Condition(s): Pain
19
Terminated
Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL)
Last Updated: February 5, 2008
Condition(s): Chronic Lymphocytic Leukemia
20
Completed
OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients
Last Updated: May 25, 2007
Condition(s): Pain; Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Cephalon

Page 1 of Clinical Trials for Cephalon [SPONSOR-COLLABORATORS], 166 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About